Nektar Therapeutics (0UNL) Revenue
Nektar Therapeutics Revenue
Nektar Therapeutics had a revenue of 10.13M in the quarter ending Jun 30, 2026, with -6.72%. This bring the company's revenue in the last twelve months to 54.59M, Decreased 1.88%. In the fiscal year ending Dec 31, 2025, Nektar Therapeutics had annual revenue of 55.23M with -43.89% growth.
- Revenue (ttm)
- 54.59M
- Revenue Growth
- -27.15%
- P/S Ratio
- 24.03
- Revenue/Employee
- $876,698
- Employees
- 63
- Market Cap
- $1.33B
Revenue Chart
Nektar Therapeutics Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 55.23M | -43.20M | -43.89% |
| Dec 31, 2024 | 98.43M | 8.30M | 9.22% |
| Dec 31, 2023 | 90.12M | -1.93M | -2.10% |
| Dec 31, 2022 | 92.06M | -9.85M | -9.67% |
| Dec 31, 2021 | 101.91M | -51.01M | -33.36% |
| Dec 31, 2020 | 152.91M | 38.30M | 33.41% |
| Dec 31, 2019 | 114.62M | -1.08B | -90.40% |
| Dec 31, 2018 | 1.19B | 885.61M | 287.81% |
| Dec 31, 2017 | 307.71M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.